AXS 2024 Assembia
28 April – 2 May
Las Vegas, US
News & Events
Recent news and forthcoming events
Keep up to date with Genesis Research Group's recent news and live events. Discover at which pharmaceutical, medical device, and biotech events you can catch up with our team.
Recent news and live events
Genesis Research Group announces appointment of David W. Miller as CEO
A seasoned executive with more than 25 years in the biopharmaceutical industry, David Miller will lead the Group’s next phase of growth to revolutionize healthcare research. Frank A. Corvino appointed…
Read More
Webinar – Fit-for-purpose matchmaking: A data selection and RWE approach for both regulatory and HTA audiences
On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar…
Read More
Genesis Research Group appoints Lynn Okamoto as Chief Business Officer
Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Lynn Okamoto as Chief Business…
Read More
Genesis Research Group strengthens Board of Directors with appointments of Professor Carole Longson MBE and Dr. S. Yin Ho, M.D., M.B.A.
Genesis Research Group, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has announced the appointment of Professor Carole Longson MBE and Dr.…
Read More
Don’t miss our insights and evidence webinar
Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access' at…
Read More
Leading pharmaceutical executive Jennifer Fillman joins Genesis Research Group as Chief Financial Officer
International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research Group has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to…
Read More
Genesis Research Group and Syapse combine forces to offer RWE and data to oncology innovators
Genesis Research Group is delighted to announce a strategic partnership with Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world…
Read More
Genesis Research Group and COS announce innovative partnership
We are delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS). As the regulatory landscape with respect to RWE continues to evolve,…
Read More
Genesis Research Group at ISPOR 2022
From May 16-18, 2022, the Genesis Research Group leadership, including Joseph DiCesare, Frank A. Corvino, Marlene Smurzynski, Chris L. Pashos, Deborah Casso, Stephen Ralston, Weiying Wang, Julie Munakata, and Michael…
Read More
Genesis Research Group acquires Market Access Transformation, a leading provider of technology-enabled payer research platforms
Genesis Research Group, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has acquired Market Access Transformation (“MAT”), a leading provider of technology-enabled…
Read More
Upcoming events
ISPOR 2024
5 – 8 May
Atlanta, US
ASCO 2024
31 May – 4 June
Chicago, US
ISPE 2024
24-28 August
Berlin, Germany
ISPOR Europe 2024
17-20 November
Barcelona, Spain
For press and media inquiries, please email Richard Chumbley: rchumbley@genesisrg.com.
Want to hear about our latest news, webinars and events?
Sign up for our newsletter
Headquarters:
HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US